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Abstract
Background: In an effort to prevent infants being infected with SARS-CoV-2, some governments, professional
organisations, and health facilities are instituting policies that isolate newborns from their mothers and otherwise
prevent or impede breastfeeding.
Weighing of risks is necessary in policy development: Such policies are risky as was shown in the early
response to the HIV pandemic where efforts to prevent mother to child transmission by replacing breastfeeding
with infant formula feeding ultimately resulted in more infant deaths. In the COVID-19 pandemic, the risk of
maternal SARS-CoV-2 transmission needs to be weighed against the protection skin-to-skin contact, maternal
proximity, and breastfeeding affords infants.
Conclusion: Policy makers and practitioners need to learn from the mistakes of the HIV pandemic and not
undermine breastfeeding in the COVID-19 pandemic. It is clear that in order to maximise infant health and
wellbeing, COVID-19 policies should support skin-to-skin contact, maternal proximity, and breastfeeding.
Keywords: COVID-19, HIV, Prevention of mother-to-child-transmission, Infant and young child feeding in
emergencies, Policy development
Background
The care of mothers and infants in the COVID-19 pan-
demic has proven challenging, as policy makers have
grappled with how to protect newborns when their
mothers are suspected or confirmed as having COVID-
19. For the general population, isolation of the infected
from the uninfected and physical distancing are essential
to preventing disease transmission and achieving good
health outcomes. However, mothers and infants present
a special situation as the risk of mother-to-child trans-
mission of SARS-CoV-2 needs to be weighed against the
protection from infectious diseases and the support for
bonding and caregiving provided by close maternal
proximity and breastfeeding.
In low-, middle- and high-income countries, some pol-
icy makers and practitioners appear to have given more
weight to the risk of SARS-CoV-2 transmission than the
consequences of maternal separation and reducing
breastfeeding. At the most extreme, infants are being
isolated from their mothers with suspected or confirmed
COVID-19 for periods of up to 2 weeks (e.g. [1, 2]). In
some contexts, expressed breastmilk may be provided,
while in others even provision of breastmilk is prohib-
ited. More commonly, skin-to-skin contact after birth is
being withheld and where infants are permitted to share
a room with their mothers, a distance of two meters or a
screen separates them (e.g. [3, 4]). These decisions re-
duce infant access to breastfeeding and breastmilk and
have been made on the basis of very little evidence. A
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similar weighing against breastfeeding was made in the
early response to the HIV pandemic.
Discussion
Experience of the HIV pandemic
The possibility of mother-to-child transmission of
HIV through breastfeeding was first raised in 1985 in
a letter published in the Lancet [5]. In this case, an
Australian woman who had been given an HIV con-
taminated blood transfusion for a postpartum haem-
orrhage, contracted HIV and her infant was also
found to be HIV positive [5]. It was proposed that
the mother transmitted HIV to her infant through
breastfeeding. Shortly thereafter, HIV was isolated in
breastmilk [6]. The fear of mother-to-child transmis-
sion of HIV through breastmilk led authorities in the
USA to quickly respond by recommending that HIV-
positive mothers should not breastfeed [7]. Policy
makers in the developing world followed suit and
HIV-positive women were supplied with free infant
formula despite there being no knowledge of the
magnitude of risk of HIV transmission through
breastfeeding [8].
Replacement infant formula feeding by HIV-positive
women was quickly institutionalised in many countries.
However, it was not until 1992 that a reliable estimate of
HIV transmission through breastmilk was published in-
dicating that after 24 months of breastfeeding 14% of
breastfed infants risked contracting HIV [9]. Further re-
search highlighted that this was the cumulative risk and
not, as supposed, a one-off risk when mothers com-
menced breastfeeding, and breastfeeding for a shorter
period of 6 months carried a risk of about 4% [10]. In
addition, if breastfeeding during the first 6 months was
exclusive, this risk was even further diminished. It
emerged that supporting exclusive breastfeeding maxi-
mized infant HIV-free survival [11].
Rather than improving infant health, policies to
move away from supporting breastfeeding in the
HIV pandemic had a devastating impact on infant
mortality in many middle- and low-income coun-
tries. More infants lost their lives through diarrhoea
and pneumonia related to infant formula feeding
compared to those who lost their lives through HIV
infection [11]. The hard lesson was learnt that an
HIV negative dead infant is still dead. The aftermath
of these recommendations had serious repercussions
that lasted for more than a decade as the fear of
HIV transmission and the normalisation of bottle
feeding changed infant feeding practices. Even in
communities that previously had a strong breastfeed-
ing culture, mothers who were HIV-negative opted
to infant formula feed with attendant increases in in-
fant morbidity and mortality [11].
Differences between HIV and SARS-CoV-2 infection in
infants
While policy development in the HIV pandemic might
share some similarities with the COVID-19 pandemic,
the method of transmission and the impact of infection
on infants are quite different. HIV is a blood borne in-
fection that can be transmitted in utero, during birth,
and via breastmilk [12]. HIV can cause serious disease,
and before the introduction of effective anti-retroviral
treatment, mortality rates of those infected with HIV as
infants approached half by 3 years of age [13].
In contrast, SARS-CoV-2 appears to be primarily
transmitted through respiratory droplets and contact
routes [14]. To date there is no clear evidence that verti-
cal transmission occurs and samples of amniotic fluid,
and cord blood taken from mothers with confirmed
COVID-19 have been found negative for SARS-CoV-2
[15]. In a small number of cases, viral RNA particles
have been detected in expressed breastmilk, but no live
virus has been found and breastmilk is not thought to be
a transmission route [16, 17]. Antibodies to SARS-CoV-
2 have been found in breastmilk suggesting that breast-
feeding may provide specific protection against the virus
[18]. A recent review of infants born to 655 women with
COVID-19 concluded that it was rare for infants to be
infected with SARS-CoV-2 and that rates of infection
are not increased when infants remain proximate to
their mothers and breastfeed [17]. Children infected with
SARS-CoV-2 are mostly asymptomatic or have mild
symptoms [19]. It seems that fever and cough are rela-
tively the most reported symptoms amongst paediatric
cases and many children with SARS-CoV-2 infection
might remain undetected. Complications and death ap-
pear to be rare [19].
As described, HIV and COVID-19 are starkly different
in terms of transmission method and consequences of
transmission. Nonetheless, it should be noted that des-
pite the possibility of HIV being transmitted via breast-
milk and that, prior to antiretroviral use, infection with
HIV was commonly fatal, policies to move away from
breastfeeding in the HIV pandemic caused great harm.
Since there is no evidence that SARS-CoV-2 is transmit-
ted via breastmilk and COVID-19 is rarely serious in in-
fants, the relative harm of policies impeding
breastfeeding in the COVID-19 pandemic may therefore
be even greater than was the case for the HIV pandemic.
World Health Organization guidance
On 13 March 2020 the WHO published interim guid-
ance on the clinical management of COVID-19, includ-
ing on the care of newborn infants [20]. This guidance
was heavily weighted towards supporting maternal prox-
imity and breastfeeding. It states that women with sus-
pected, probable or confirmed COVID-19 should be
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supported to have their infants placed skin-to-skin with
them immediately after birth, initiate breastfeeding
within an hour of birth, to keep their infants by their
side day and night, and exclusively breastfeed [20].
Alongside these practices, mothers should apply infec-
tion prevention and control measures by practicing re-
spiratory hygiene, washing their hands before and after
contact with their infants, and ensuring that surfaces
that they have been in contact with are cleaned and dis-
infected [20]. Where mothers are unable to breastfeed
because of illness they are to be assisted to express milk
for their infants [20]. If this is not possible, the use of
donor human milk should be explored and if this is not
available wet nursing or infant formula may be consid-
ered. Ongoing milk expression and relactation when
mothers are well enough is also recommended [20].
Infographics to assist in the promotion of the guidance
were released by the WHO, as shown in Figs. 1, 2 and 3.
The WHO released updated guidance on the manage-
ment of COVID-19 on 27 May 2020, the recommenda-
tions regarding maternal and newborn care were
unchanged [21]. The rationale for these recommenda-
tions is based on the importance of breastfeeding in pre-
venting infant morbidity and mortality [20–22].
Importance of breastfeeding
Worldwide, 72% of hospital admissions for diarrhoea
and 57% of admissions for respiratory infections can be
attributed to a lack of breastfeeding [23]. In low- and
middle- income countries, infants who are not breastfed
have a mortality rate that is eight times greater than ex-
clusively breastfed infants and globally more than 800,
000 lives could be saved if breastfeeding were universally
practiced [23]. Even in high-income countries, hospital-
isation rates are greatly elevated in non-breastfed infants
[24]. The WHO COVID-19 guidance, notes that health
service practices should minimise disruption to breast-
feeding [21]. However, COVID-19 policies that require
isolation of mothers and infants and denial of breastmilk
prevent infants from having access to breastfeeding.
Withholding skin-to-skin contact after birth reduces
rates of exclusive breastfeeding by one third and
Fig. 1 WHO infographic supporting maternal proximity, skin-to-skin
contact, and breastfeeding for women who have COVID-19
Fig. 2 WHO infographic illustrating the hygiene measures to be
undertaken by breastfeeding women who have COVID-19
Fig. 3 WHO infographic presenting breastmilk options if mothers
are too ill with COVID-19 to breastfeed
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impedes maternal bonding and sensitivity [25, 26]. Any
increase in physical distance between mothers and in-
fants reduces the frequency of breastfeeding and may
therefore negatively impact on the establishment of
breastfeeding [27]. Reduction of breastfeeding not only
has an impact on infant physical health, but adversely
impacts infant cognitive development [28]. It can also
reduce maternal caregiving capacity and so result in in-
creased rates of child maltreatment [29]. Maternal
deaths due to breast and ovarian cancers as well as type
2 diabetes can also be attributed to short breastfeeding
duration practices [28].
Exploitation of the pandemic by the infant formula
industry
Policies that impede breastfeeding also enhance the mar-
keting of infant formula as manufacturers can argue that
normal prohibition on donations of infant formula do
not apply because mothers cannot breastfeed. Donations
are a powerful marketing tool that are proscribed by the
WHO International Code of Marketing of Breastmilk
Substitutes and the Operational Guidance on Infant and
Young Child Feeding in Emergencies [30, 31]. However,
in the COVID-19 pandemic, infant formula manufac-
turers and distributors are donating to hospitals, govern-
mental and non-governmental agencies, and individuals
worldwide [32–34]. The negative short and long-term
harms of donations in emergencies are well known [35].
At all times, but especially in emergencies, protection
and support for breastfeeding needs to be strengthened
and not undermined [36].
Conclusion
COVID-19 policy makers must learn from past mistakes.
In 2010 this journal published a thematic issue on “HIV
and Infant Feeding: Lessons Learnt and Ways Ahead” in
which Moland et al. [37] concluded, “The scientific evi-
dence base warns against hasty dismissal of the evolved
benefits of breastfeeding … In future, the global health
professional community should be more sceptical of
claims about the risks of breastfeeding.” We stand now in
the future spoken of, facing a new pandemic. With such
substantial, well documented evidence of the importance
of maternal proximity and breastfeeding for child sur-
vival, development, and health as well as the protection
that breastfeeding affords mothers, we cannot repeat the
mistakes of the HIV pandemic. Breastfeeding should not
be interrupted because of a fear that SARS-CoV-2 could
be transmitted from mothers to infants during breast-
feeding and so harm infants. Countries, professional as-
sociations, and health facilities should follow the lead of
the WHO, taking heed of the experiences of the past
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